Intrepid Financial Planning Group LLC Acumen Pharmaceuticals, Inc. Transaction History
Intrepid Financial Planning Group LLC
- $234 Million
- Q4 2024
A detailed history of Intrepid Financial Planning Group LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Intrepid Financial Planning Group LLC holds 30,150 shares of ABOS stock, worth $41,908. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,150
Previous 30,150
-0.0%
Holding current value
$41,908
Previous $74,000
31.08%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ABOS
# of Institutions
81Shares Held
40.6MCall Options Held
28.6KPut Options Held
76.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$20.8 Million0.42% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.75 Million2.23% of portfolio
-
Franklin Resources Inc San Mateo, CA3.27MShares$4.55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.7 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $56.3M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...